Webinar | Radiation Dose Management| August 27, 2021

The Editorial Roundtable will be held September 16 at 2 pm ET/ 1pm CT

Through the use of technology, clinicians can better fine-tune department performance, automate documentation for improved reporting accuracy, facilitate compliance with certification programs and regulatory requirements, and ensure contrast dose management across and imaging department or enterprise

A holistic view of contrast and radiation dose data is imperative to help identify opportunities for clinical and operational improvement at both the patient and enterprise levels. With the advent of digital platforms, radiologists are now able to analyze data, optimize standardization and problem-solve in real time. This approach helps drive standardization for personalized care for patients.

Through the use of technology, clinicians can better fine-tune department performance, automate documentation for improved reporting accuracy, facilitate compliance with certification programs and regulatory requirements, and ensure contrast dose management across and imaging department or enterprise.

In this roundtable discussion discussion hosted by ITN Editorial Director Melinda Taschetta-Millane, three medical experts will discuss the topic of assuring dose quality for interventional radiology (IR) and fluoroscopy. Featured are three experts in diagnostic and radiological medical physics.

REGISTER NOW

Learning Objectives

How to assure dose quality in interventional and fluoroscopy suites. How to get support from your compliance team to train surgeons and clinicians on dose quality. Best practices for ALARA and decreasing dose. Best practices for organizations looking to optimize their fluoroscopy dose management.

 

Featured Speakers

 

Emily Marshall, Ph.D.

Emily Marshall, Ph.D., is an Assistant Professor of Radiology and a Clinical Diagnostic Physicist at the University of Chicago. She serves as a faculty member on the Graduate Program's Committee on Medical Physics at the University of Chicago. Historically, her research has focused on the development of translational radiation dosimetry models for application in the fluoroscopic imaging of pediatric patient populations. Moving forward, her clinical interests emphasize imaging application optimization in pediatric patient populations.

 

Mark Supanich, Ph.D.

Mark Supanich, Ph.D., is head of the division for Diagnostic Medical Physics in the Department of Radiology and Nuclear Medicine at Rush University Medical Center in Chicago. He has extensive experience in computed tomography imaging operation, image quality and radiation dose assessment, and is chair or co-chair several committees related to CT in professional organizations. Supanich is actively involved in clinical research on a number of quantitative imaging topics, including a pilot project on lung nodule volumetry with a collaborator the University of Chicago.

 

John Harvey, Ph.D.

John Harvey, Ph.D., is a board-certified diagnostic medical and health physicist for West Physics. Prior to joining the organization, Harvey completed his Ph.D. at the University of Michigan in health physics. His research focused on the deployment of thermoluminescent radiation dosimeters in non-ideal conditions. He has also participated in research into the computer-aided analysis of mammography and lung CT imaging, which can provide radiologists with a computerized second opinion for cancerous lesions. During his tenure at West Physics, Harvey has surveyed numerous types of fluoroscopes; developed and delivered fluoroscopy radiation safety lectures and hands-on training in hospitals nationwide; counseled physicians on their fluoroscopy use during diagnostic and treatment procedures; performed patient, worker, and fetal dose calculations; investigated radiation overexposures; and has served as Radiation Safety Officer for a hospital network with locations throughout Georgia, a Level 1 Trauma Center in downtown Atlanta, a cancer research facility, a nationwide mobile nuclear medicine/PET provider, and an international narcotics and explosives detector manufacturer.

REGISTER NOW

Sponsored by Bayer

Bayer is a leader in meeting the needs of Radiology programs and professionals. Bayer offers an end-to-end support system, ranging from contrast agents and power injection systems and their sterile disposables to equipment services and enterprise informatics.


Related Content

News | Cardiac Imaging

November 29, 2022 — Researchers have developed a deep learning model that uses a single chest X-ray to predict the 10 ...

Home November 29, 2022
Home
News | Cardiac Imaging

November 28, 2022 – UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power ...

Home November 28, 2022
Home
News | Cardiac Imaging

November 28, 2022 — Konica Minolta Healthcare Americas, Inc., a leader in medical diagnostic imaging and healthcare ...

Home November 28, 2022
Home
Feature | Cardiac Imaging

Discover the key features of cardiovascular structured reporting that drive adoption, including automated data flow, EHR ...

Home November 07, 2022
Home
News | Cardiac Imaging

October 18, 2022 — HeartFlow, Inc., a leader in revolutionizing precision heart care, has received U.S. Food and Drug ...

Home October 18, 2022
Home
Webinar | Cardiac Imaging

The direct impact of COVID-19 is substantial. The resulting impact of the pandemic has forced healthcare organizations ...

Home October 17, 2022
Home
News | Cardiac Imaging

October 11, 2022 — Researchers from the University of Minnesota Medical School found that patients with certain features ...

Home October 11, 2022
Home
News | Cardiac Imaging

September 2, 2022 — A randomized trial in more than 45,000 men has suggested that cardiovascular screening including ...

Home September 02, 2022
Home
News | Cardiac Imaging

September 2, 2022 — In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was ...

Home September 02, 2022
Home
News | Cardiac Imaging

August 25, 2022 — Imperfect current propagation in the heart is at the root of most cardiac diseases. Thanks to a novel ...

Home August 25, 2022
Home
Subscribe Now